<DOC>
	<DOC>NCT03035825</DOC>
	<brief_summary>This randomized control trial aims to investigate the efficacy of oral moisturizing jelly in head and neck cancer patients with xerostomia.</brief_summary>
	<brief_title>Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients</brief_title>
	<detailed_description>Oral moisturizing jelly is a novel edible, gel-based artificial saliva. It has been proven effective in reducing dry mouth sign and symptoms in elderly patients with xerostomia. This randomized control trial intends to determine if continuous use of oral moisturizing jelly may be effective in reduction of signs and symptoms of dry mouth, improvement of biochemical properties of saliva, subjective swallow ability, appetite, tolerance to spicy food, energy intake and reduce umami taste recognition threshold.</detailed_description>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Xerostomia</mesh_term>
	<criteria>1. Xerostomic head and neck cancer patients who finish radiotherapy for at least 1 month. 2. If undergoing chemotherapy, have to finish for at least 2 weeks. 3. Have subjective dry mouth scores at least 3 4. Can perform oral intake without aspiration 5. Can communicate well 1. Has recurrence of cancer 2. Has mucositis more than grade 1 3. Has oral infection such as candidiasis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>